InvestorsHub Logo
Followers 5
Posts 672
Boards Moderated 0
Alias Born 01/09/2009

Re: None

Friday, 12/13/2013 5:54:41 AM

Friday, December 13, 2013 5:54:41 AM

Post# of 48316
Just a couple positive thoughts for the day:

You have a promising treatment that has shown documented results against one of the nastiest forms of cancer (Merkel Cell) with ongoing clinical trials and soon expected results.

You have an Executive Director of a fortune 500 (57 or 58) leaving to come work for a little podunk upstart pharma wannabe. Probably being given a boat load of stock options in lieu of millions in cash.

The aforesaid makes a statement such as ...

"We stand at a transformational moment in oncology. I'm convinced that intralesional therapy with IL12 drives systemic anti-tumor immune responses and has the potential to augment immunomodulatory therapies such as anti-PD-1."

Just gives you a good feeling IMHO.

Most importantly let's hope for a viable treatment for the sufferers.